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Abstract To explore the effect of T2DM on cerebral perfu-
sion, and the relationship between cerebral perfusion changes
and cognitive impairment as well as diabetic variables, by
using a whole-brain arterial spin-labeling (ASL) MRI tech-
nique. This prospective study was approved by the local in-
stitutional review board and was performed between
November 2012 and October 2013. All subjects provided in-
formed consent. Forty T2DM patients and 41 age-, sex- and
education-matched healthy controls were included. Cerebral
blood flow (CBF) map was obtained by pulsed ASL perfusion
imaging at 3 T MRI. Voxel-wise comparisons on CBF maps
with and without partial volume effects (PVEs) correction
were performed between groups. Associations between CBF
and cognitive functioning, and between CBF and diabetic
variables were investigated by using voxel-wise, whole-
brain correlation analyses. In T2DM patients, PVEs uncor-
rected CBF was decreased in the posterior cingulate cortex
(PCC), precuneus and bilateral occipital lobe, and increased
in the anterior cingulate cortex (corrected P < .05). These
changes were largely unchanged after PVEs correction.
Correlation analyses revealed that in patients, hypoperfusion
in PCC and precuneus regions were related to higher insulin
resistance level and deficits in clock-drawing performance,
while the occipital hypoperfusion was associated with worse
visual-memory performance, regardless of PVEs correction.
The cerebral hypoperfusion pattern in T2DM resembles the
pattern observed in the early stage of dementia, and increased
insulin resistance might be an important risk factor as well as
treatment target for such CBF dysregulation.
Keywords Cerebral perfusion . Type 2 diabetes . Insulin
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Introduction
Type 2 diabetes mellitus (T2DM) is a prevalent metabolic
disorder characterized by insulin resistance. A convergence
of evidences has suggested T2DM to be associated with in-
creased risk for cognitive impairment and dementia
(Geijselaers et al. 2015). In the general population, cerebral
blood flow (CBF) dysregulation is considered a risk factor for
developing cognitive dysfunction (Ishiwata et al. 2006; Jagust
et al. 1997). A growing number of studies on T2DM patients
have demonstrated an association between hyperglycemia and
cerebrovascular pathology (Almdal et al. 2004; Biessels et al.
2002), which might lead to the chronic and insidious ischemia
of the brain (Biessels et al. 2006). Therefore, disturbances in
cerebral perfusion are often hypothesized an important etiol-
ogy of cognitive deficits in T2DM subjects.
However, the relation between cerebral perfusion, cogni-
tion and T2DM has not been well documented. Results from
current few studies are inconsistent, some of which reported
various degrees of impaired hemodynamics or vasoreactivity
(Brundel et al. 2012; Novak et al. 2006; Last et al. 2007),
while the others observed no difference comparing with
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healthy cohorts (Rusinek et al. 2015; Tiehuis et al. 2008;
Dandona et al. 1978). This discrepancy might on one hand
reflect the methodological differences in assessing CBF; more
importantly, these studies primarily focused on the overall
changes in global or cortical CBF, which may overlook the
potential regional-specific effects caused by T2DM.
Compared with global/cortical CBF, regional measurements
are probably more advantageous to reveal localized alter-
ations, which is often the case observed in earlier stage of
cognitive decline (Johnson et al. 2005). Given the usually
intact general cognitive functioning in T2DM patients (Ryan
and Geckle 2000), a voxel-wise CBF measurement might be
of higher sensitivity and specificity in tracking the early ef-
fects of diabetes on cerebral perfusion.
Arterial spin labeling (ASL) perfusion MRI is a noninva-
sive and sensitive imaging technique for CBF measurement
(Williams et al. 1992). It labels the arterial blood water in the
brain and uses it as an endogenous tracer, providing unique
advantages over other imaging modalities that are often lim-
ited by exogenous contrast agents and imprecise prediction
based on macrovascular flow. Compared with blood-
oxygen-level dependent (BOLD) contrast MRI widely used
in neural activity detection, ASL MRI reflects a more direct
neurovascular coupling and permits quantitative measurement
of CBF, which is less confounded by head motion artifacts
(Detre andWang 2002). With these advantages, ASL imaging
has been used in studies of cerebrovascular and psychiatric
disorders, yielding reliable and reproducible quantitative
CBF measurement (Johnson et al. 2005; Le Heron et al.
2014).
The present study, therefore, used whole-brain ASL MRI
technique to explore the cerebral perfusion changes in T2DM,
and their relationship with cognitive impairment. We studied
both partial volume effects (PVEs)-uncorrected and PVEs–
corrected CBF maps to account for potential confounds by
cortical atrophy. We hypothesized that 1) T2DM patients
would exhibit alterations in cerebral perfusion, which is inde-
pendent of cortical volume change; 2) the altered perfusion
would correlate with impaired cognitive performance and spe-
cific diabetic variables in T2DM patients.
Methods
Subjects
This prospective study was approved by the local Research
Ethics Committee and was performed between November
2012 and October 2013. All subjects provided their written
informed consent before participation. Forty diabetic patients
and 41 healthy controls were recruited from the local hospital
and community via advertisement, respectively. Inclusion
criteria included right-handedness, aged 50–70 years, and at
least 6 years of education. Exclusion criteria consisted of al-
cohol or substance abuse, Mini-Mental State Examination
(MMSE) score < 24, Hamilton Depression Rating Scale
(HAM-D) score ≥ 7, past or current brain lesion, unrelated
psych i a t r i c o r neu ro log i ca l d i so rde r and MRI
contraindications.
Diagnosis of T2DM was based on the latest criteria of
American Diabetes Association (American Diabetes 2012).
All patients were under close self-monitoring and received
treatments including diet restriction, insulin, oral medications
or combination therapy, with none having current or past his-
tory of hypoglycemia. To minimize the heterogeneity, patients
who reported or were diagnosed with diabetic complications
such as retinopathy, nephropathy, or neuropathy were exclud-
ed. Healthy subjects were matched with patients on age, gen-
der and years of education.
Biometric measurements
Blood samples were collected after overnight fasting to ac-
quire FPG, HbA1c, fasting insulin and lipid level. Controls
with fasting plasma glucose (FPG) level > 5.6 mmol/l or a 2 h
postprandial glucose level > 7.8 mmol/l were considered at
pre-diabetes state (American Diabetes 2012) and excluded
from the study. During the visiting day, medical history, med-
ication use, body weight, height, waist circumferences and
blood pressure were also measured and recorded. Insulin re-
sistance (IR) was determined by homeostasis model assess-
ment of insulin resistance (HOMA-IR) for all participants ex-
cept for those with insulin treatment.
Cognitive assessment covering several domains was per-
formed by an experienced neurologist blind to the group allo-
cation. Episodic memory regarding verbal and visual informa-
tion was assessed by the Auditory Verbal Learning Test
(AVLT) and Rey-Osterrieth Complex Figure Test (CFT)-de-
layed recall trial, respectively; working memory was mea-
sured by the forward and backward trials of the digit span test
(DST); attention was evaluated by the Trail Making Test part
A (TMT-A); executive functioning was assessed by Trail
Making Test part B (TMT-B); visuo-spatial and attention
was assessed by the Clock Drawing Test (CDT) and the
CFT-copy trial.
Image acquisition
MRI scanning was conducted on a Siemens 3 T Trio scanner
(Erlangen, Germany). Subjects were instructed to keep their
eyes closed, remain awake, avoid specific thoughts and keep
their heads still during the scanning. ASL sequence was ac-
quired by the following parameters: slice =27, repetition time
(TR) = 4000 ms, echo time (TE) = 12 ms, slice thick-
ness=4mm, flip angle=90°, field ofview=220mm×220mm,
acquisition matrix =64 × 64, number of controls/labels =52
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pairs. T1-weighted magnetization-prepared rapid gradient-
echo imaging (MPRAGE) sequence was acquired to facilitate
functional image preprocessing: section =176, TR = 1900 ms,
TE = 2.48ms, slice thickness = 1.0 mm, flip angle =9o, field of
view =250 mm × 250 mm, acquisition matrix =256 × 256.
Finally, fluid-attenuated inversion recovery (FLAIR) images
were obtained: TR = 8500 ms, TE = 94 ms, slice =20, slice
thickness = 5 mm. The potential small vessel disease (SVD)
defined as white matter hyperintensity (WMH) and lacunar
infarcts were evaluated on the FLAIR images as previously
described (Wahlund et al. 2001). Briefly, the brain was divided
into five regions on each hemisphere, and theWMH score was
rated on each region separately on a 4-point scale (from 0 to
3), resulting in a final score ranged from 0 to 30. Participants
with a score of 3 in any region were considered to have severe
SVD and were thus excluded.
Data processing
ASL data were analyzed using the Analysis of Functional
Neuroimages (AFNI) software (National Institute of Mental
Health, Bethesda, Maryland) (Cox 1996). At first, control and
label ASL images were co-registered to each other, with head
motion corrected and were smoothed with a 6-mm Gaussian
kernel. The CBF-weighted time series were obtained by sur-
round subtraction of the control and label images using sinc-
interpolation. Quantitative CBF was calculated using the fol-
lowing model (Wang et al. 2003):
f pASL x; y; zð Þ ¼
λ⋅ΔM x; y; zð Þ
2αM 0 x; y; zð ÞTI1exp − TI2T 1B
 
fpASL(x, y, z) is the blood flow at voxel (x,y,z) in milliliters
per minute per 100 g brain tissue; ΔM is the CBF-weighted
images and M0 is the fully relaxed image intensity; blood/
tissue water partition coefficient λ = 0.9 mg/L; inversion effi-
ciency α = 95 %; duration between inversion and saturation
pulses TI1 = 600 ms; image acquisition time TI2 = 1600 ms;
longitudinal relaxation time of blood T1B = 1.624 s at 3.0
Tesla (Lu et al. 2004). Afterwards, the quantitative CBF image
was co-registered to each subject’s T1-weighted image and
spatially normalized to the Montreal Neurologic Institute
(MNI) standard space with a resolution of 3 × 3 × 3 mm3.
To obtain perfusion information from primarily cortical
regions, T1-weighted images were segmented to create prob-
abilistic gray matter (GM) and white matter (WM)maps using
Statistical Parametrical Mapping 8 (SPM8) software
(http://www.fil.ion.ucl.ac.uk/spm/). The GM map was
resampled to the resolution of the perfusion image and
converted to a binary mask thresholded at 20 % probability
to exclude voxels with small amounts of GM and then applied
on the perfusion data. Finally, to reduce the effects of inter-
subject variations in global CBF that is associated with non-
neural factors and noise, the resultant CBF value was normal-
ized by the global GM mean CBF, yielding an uncorrected
relative CBF (CBFuncorr) map. This normalization strategy is
widely applied in PET and ASL studies to improve sensitivity
(Borghammer et al. 2008).
PVEs correction
In CBF calculation, correction for partial volume effects
(PVEs) is often performed to account for potential GM atro-
phy that may result in biased perfusion in voxels with greater
volume fractions of WM and CSF (Johnson et al. 2005). We
therefore performed the PVEs correction using the following
formula (Johnson et al. 2005): SIcorr = SIuncorr / (GM +
0.4 × WM), where SIcorr and SIuncorr are corrected and uncor-
rected signal intensities. A similar normalization strategy was
also applied as during the CBFuncorr calculation, yielding the
corrected relative CBF (CBFcorr) map for each subject.
Statistical analysis
Clinical characteristics
Statistical analyses were performed using SPSS software (ver.
18.0; SPSS, Inc., Chicago, IL, USA). Normal distribution was
tested by the Kolmogorov-Smirnov test. Group comparison of
clinical parameters were conducted using independent two-
sample t-test for normally distributed variables, nonparametric
Mann-Whitney U test for asymmetrically distributed vari-
ables, and χ2-test for categorical variables. A two-tailed
P < 0.05 was considered statistically significant.
Voxel-wise analysis of ASL data
Group average CBFuncorr and CBFcorr value in each group
were first calculated. Group effects on both CBF maps
were analyzed using a voxel-wise general linear mixed-
effects model, with age, gender and years of education as
covariates. The education level was treated as a covariate of
no interest to minimize its potential effects on cerebral per-
fusion as well as brain size (Chiu et al. 2004; Coffey et al.
1999). To exclude the confounding effects of SVD, pres-
ence of hypertension, hyperlipidemia, lacunar infarcts and
WMH score were further controlled. The comparison was
confined in GM mask obtained from the overlap of seg-
mented GM images of all subjects. Statistical significance
was set at two-tailed Pcorrected < 0.05 (uncorrected P < 0.01
with a cluster of 53 voxels, determined by AFNI AlphaSim
correction).
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Gray matter voxel-based morphometry analysis
Cortical volume changes were explored by voxel-based mor-
phometry (VBM) analysis based on SPM8 software. The seg-
mented GM maps in MNI space were modulated and
smoothed with 8-mm Gaussian kernel. The maps were then
compared between groups, with two-tailed P < 0.05 as statis-
tical significance (uncorrected P < 0.01 combined with a clus-
ter size of 232 voxels). Brain volumes in GM, WM and CSF
as well as the total brain volume (sum of the three parts) were
also compared.
Correlations between perfusion and clinical data
The correlations between CBF maps (both uncorrected and
corrected), diabetes variables (i.e., FPG, HbA1c and
HOMA-IR) and neurocognitive performance that were signif-
icantly differed between groups (i.e., CFT-delay, CDT and
TMT-B) were explored in a who-brain linear regression mod-
el, using the AFNI’s 3d LME command. The CBF maps and
clinical variables in both groups were entered into the models.
To identify the regions where the perfusion was differentially
correlated with clinical variables in patients vs. controls, we
focused on the group × variable statistical maps (two-tailed
Pcorrected < 0.05, Pvoxel-wise < 0.01). Brain regions with signif-
icant interaction effects were considered important in contrib-
uting to the T2DM-related cognitive impairment. All analyses
were adjusted for the same covariates as during the group
comparison.
Additionally, to investigate the effects of glycemic control
and treatment modality on brain perfusion, patients were ei-
ther stratified according to HbA1c level (above and below
7 %) or treatment modality (diet restriction, oral
hypogelycemic agents and insulin). The mean CBFcorr and
CBFuncorr values were extracted from each region with group
differences and compared among these sub-groups.
Results
Demographic and cognitive characteristics
None of the participants was excluded because of severe SVD.
The demographic and cognitive characteristics were summa-
rized in Table 1. T2DM patients and controls were well
matched for age, gender, education, head motion, blood lipid
level, blood pressure, WMH and lacunar infarcts. As expect-
ed, the FPG, HbA1c and HOMA-IR level in the T2DM group
were significantly higher (P < 0.05). Patients performed sig-
nificantly worse on CFT-delay, TMT-B and CDT (P < 0.05),
which involve multiple cognitive domains including memory,
executive functioning and spatial processing. In T2DM group,
disease duration was negatively correlated with performance
in CFT (R = −0.496, P < 0.01) and CFT-delay (R = −0.35,
P = 0.02). No correlations were found among other clinical
parameters.
Voxel-wise CBF differences
The average CBFuncorr and CBFcorr maps are shown in Fig.1.
In each group, perfusion in occipital lobe, temporal lobe and
the putative default-mode network (DMN) regions including
posterior cingulate cortex (PCC), precuneus and MPFC were
higher than other regions, which is consistent with previous
results (Liang et al. 2013).
Comparedwith controls, T2DMpatients showed decreased
CBFuncorr in PCC, precuneus and bilateral middle occipital
gyrus (MOG) (Fig. 2a, cool color), but increased CBFuncorr
in the dorsal anterior cingulate cortex (dACC) (Fig. 2a, warm
color). These results remained largely unchanged after the
PVEs correction, except that the cluster size of PCC shrunk
and did not survive the multiple comparison correction
(Fig. 2b). A detailed list of the identified brain regions is
summarized in Table 2. Notably, the global average CBF did
not show significant group difference, indicating the early
effects of T2DM on brain perfusion being more localized
rather than globalized (Fig. 2, right column).
Gray matter voxel-based morphometry analysis
During the VBM analysis, no suprathreshold voxel-wise dif-
ference was observed in the GM concentration between the
two groups. Through brain volume comparison, we found that
T2DM patients showed a larger CSF volume than the HCs.
However, the GM, WM and total volume did not differ be-
tween groups (Supplementary Table 1).
Associations between CBF and clinical measurements
During the correlational analyses, no group × variable inter-
action effect was detected in any of the clinical variables. We
next performed the voxel-wise correlational analyses using
the same clinical variables and covariates as in the interaction
model in each group separately. In T2DM group, disease du-
ration was also included in the clinical variables. Due to the
significant relationship between disease duration and CFT-
delay performance, the former was further controlled in addi-
tion to the original covariates while exploring the correlation
between CBF and the related performance. In T2DM group,
HOMA-IR was negatively correlated with the perfusion in
extensive posterior regions, especially in the precuneus and
PCC (R2 = 0.35 [CBFuncorr map], R
2 = 0.25 [CBFcorr map])
(Fig.3, first row). Performance in CDT was also positively
correlated with the perfusion in similar regions, especially
the PCC region (R2 = 0.34 for both maps) (Fig.3, second
row). Besides, the CFT-delay performance was correlated
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with the occipital perfusion after additionally controlling for
the disease duration (R2 = 0.40 [CBFuncorr map], R
2 = 0.41
[CBFcorr map]) (Fig.3, third row). Notably, no such voxel-
wise correlation was observed between CBF with other clin-
ical variables nor in the control group.
Finally, patients were stratified according to either the
HbA1c level or treatment modality to examine the contribu-
tion of these clinical parameters to the perfusion alterations.
The sample size for the patients having an HbA1c less than
7 % was 17, while the number of those having an HbA1C of
above 7 % was 23. For the sub-group treated with insulin, the
sample size was 8. The remainders were either treated with
oral hypoglycemic agents (n = 22) or diet restriction only
(n = 10). Results suggested a trend towards lower PCC/
cuneus, precuneus and occipital perfusion in patients with
poorer glycemic control (HbA1c > 7 %) (Supplementary
Fig. 1, a and c). A similar trend was also observed among
groups with different treatment modalities, where insulin-
treated patients showed the lowest perfusion in bilateral
MOG and dACCwhen comparing with those treated with oral
hypoglycemic agents and diet restriction (Supplementary
Fig. 1, b and d). However, none of these results reached sta-
tistical significance.
Discussion
Themajor findings of the present study are as follows: first, by
using ASL perfusion MRI, we identified brain regions with
hypoperfusion in T2DM patients, including the PCC,
Table 1 Demographics and clinical characteristics for T2DM and control groups
Measures T2DM (n = 40) Control (n = 41) P value
Age (years) 60.5 ± 6.9 57.9 ± 6.5 0.85
Gender (male/female)a 21/19 13/28 0.07
Education (years) 10.0 ± 3.4 10.3 ± 2.3 0.28
Head motion (FD value) 0.08 ± 0.04 0.07 ± 0.03 0.81
Diabetes duration (years) 8.9 ± 5.0 – –
Insulin treatment (n) 8 – –
HbA1c (%, mmol/mol)b 7.7 ± 1.6 (60.7 ± 16.4) 5.6 ± 0.3(37.7 ± 3.3) <0.01
FPG (mmol/L)b 7.8 ± 2.1 5.4 ± 0.3 <0.01
HOMA-IRb 3.3 ± 1.9 2.4 ± 1.1 0.02
BMI (kg/m2) 24.4 ± 2.7 23.8 ± 2.6 0.29
Systolic BP (mmHg) 136.6 ± 14.6 132.5 ± 15.0 0.21
Diastolic BP (mmHg) 86.0 ± 10.9 86.9 ± 11.3 0.77
Total cholesterol (mmol/L) 5.5 ± 1.1 5.3 ± 0.8 0.46
Triglyceride (mmol/L) 1.5 ± 0.8 1.3 ± 0.7 0.30
White matter lesions (range) 0–6 0–7 0.07
Lacunar infarcts (n)a 9 5 0.25
Cognitive performance
MMSE 28.3 ± 1.0 28.6 ± 1.2 0.09
AVLT 5.9 ± 1.4 6.5 ± 2.1 0.16
AVLT-delay 5.8 ± 2.4 6.3 ± 2.1 0.27
CFT-delayb 13.7 ± 5.5 17.3 ± 5.9 0.01
DST (forward) 6.9 ± 1.2 7.3 ± 1.6 0.37
DST (backward) 4.2 ± 0.9 4.5 ± 1.3 0.25
TMT-part A (s) 63.7 ± 12.7 63.3 ± 15.1 0.90
TMT-part B (s)b 174.3 ± 53.3 154.5 ± 50.1 0.02
CFT-copy 34.5 ± 1.5 35.0 ± 1.5 0.24
CDTb 3.2 ± 0.6 3.5 ± 0.6 0.04
VFT 16.5 ± 3.6 17.1 ± 3.2 0.48
Data are represented as mean ± (SD), n or range. a The statistical analyses were performed by χ2 test. bP value <0.05. FPG, fasting plasma glucose;
HOMA-IR, homeostasis model assessment of insulin resistance; BMI, body mass index; BP, blood pressure; MMSE, mini-mental state examination;
AVLT, auditory verbal learning test; CFT, complex figure test; DST, digit span test; TMT, trail-making test; CDT, clock drawing test; VFT, verbal fluency
test
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precuneus, and bilateral MOG, which are important structures
that often show vulnerability in the early process of neurode-
generation. Second, the observed perfusion changes were in-
dependent of potential cortical atrophy, as no cortical volume
difference was detected and the hypoperfusion pattern largely
remained after PVE correction. Finally, strong correlations
were observed between posterior hypoperfusion and IR, and
between the hypoperfusion and impaired cognitive perfor-
mance in T2DM patients. Taken together, our findings of
cerebral hypoperfusion might provide valuable insights into
the neural substrate of T2DM-associated cognitive
impairment.
The PCC and precuneus are core regions of the well-
defined default mode network (DMN), whose dysfunctions
are considered hallmarks of neurodegenerative diseases
(Greicius et al. 2004). ASL studies on AD patients showed
that cerebral perfusion reductions were most prominent in the
parietal cortices and PCC area, especially in patients at an
Fig. 1 Group average CBFcorr
and CBFuncorr maps in T2DM and
control group. Within each group,
the average relative CBFuncorr and
CBFcorr values in PCC,
precuneus, adjacent visual cortex,
MPFC and temporal regions are
higher than other brain regions.
Note that the perfusion in T2DM
group, especially in the precuneus
and occipital regions, is lower
than the control group (arrows).
Color scale denotes the relative
CBF value after normalization
with the global mean CBF. The
maps are in Montreal Neurologic
Institute standard space. R, right;
L, left. PCC, posterior cingulate
cortex; MPFC, medial prefrontal
cortex
Fig. 2 Group differences of CBFuncorr and CBFcorr maps between T2DM
patients and healthy controls (P < 0.05, Alphasim corrected). Compared
to healthy controls, T2DM patients showed significantly lower CBFuncorr
in the right PCC, precuneus and bilateral MOG (Fig. 2a, cool color). On
the other hand, patients showed higher CBFuncorr in the dACC (Fig. 2a,
warm color). The results in precuneus and MOG were largely remained
after accounting for the PVEs (Fig. 2b), but the PCC did not survive after
the multiple comparison correction. The results were mapped on cortical
surfaces using the BrainNet viewer (www.nitrc.org/projects/bnv). Color
scale denotes the T value. R, right; L, left; P, posterior. PCC, posterior
cingulate cortex; MOG, middle occipital gyrus; dACC, dorsal anterior
cingulate cortex
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earlier stage (Johnson et al. 2005). Other neurodegenerative
conditions such as aging and Parkinson’s disease also showed
similar posterior hypoperfusion patterns (Liu et al. 2012; Le
Heron et al. 2014). Similarly, parallel regions are also reported
abnormal in T2DM patients: previous study on a similar pa-
tient group found decreased neural intensity and coherence
around the precuneus regions (Cui et al. 2014); a recent PET
s tudy invo lv ing ea r ly T2DM pat i en t s r epor t ed
hypometabolism in preceneus and PCC regions that were re-
lated to higher insulin resistance level (Baker et al. 2011).
Given its consistency across neurodegenerative conditions,
such posterior hypoperfusion holds the potential to serve as
early biomarker of the cognitive impairment in T2DM.
However, it is noteworthy that the PCC did not survive after
the PVE correction, suggesting that PCC might undergo a
milder perfusion change than other posterior regions. Further
studies are warranted to study the progression of hypoperfu-
sion in more advanced patients.
Noteworthy is that the hypoperfusion in precueneus and
PCC was significantly correlated with higher HOMA-IR lev-
el. Insulin modulates various physiological activities in the
brain and is supportive of normal cognitive functioning such
as learning and memory, the reduction of which may interfere
with the glucose use and lead to neuronal dysfunction
(Lucignani et al. 1987). Therefore, IR has been increasingly
recognized to be an independent risk factor for developing
cognitive impairment (Biessels and Reagan 2015). As both
the causal factor and central characteristics of T2DM, IR is
therefore consistently suggested as an important etiology for
the onset and development of cognitive impairment (Duarte
2015). In our results, IR in T2DM group is exclusively corre-
lated with the posterior regions that are most vulnerable in
MCI and subjects at risk for AD, suggesting that IR might
be the key link for the increased incidence of AD in individ-
uals with T2DM (Kim and Feldman 2015).
Significant occipital hypoperfusion was also observed. In
T2DM patients, occipital areas have shown not only reduced
cerebrovascular reactivity, but also decreased neural activity
and brain volumes (Tchistiakova et al. 2014; Cui et al. 2014;
Espeland et al. 2013). These abnormalities in occipital regions
might be attributed to the potential visual impairment, a well-
known complication of diabetes, which often involves vascu-
lopathy and neuropathy along the visual pathway (Heravian
et al. 2012). However, since none of our included patients
manifested clinically measurable retinopathy or visual impair-
ment, whether this occipital hypoperfusion results from visual
impairment or a preferential posterior circulation impairment
needs to be further examined.
On the other hand, increased rCBF was observed along the
dorsal part of ACC, which is a critical region responsible for
higher-order cognitive control (Sheth et al. 2012). Its hyper-
perfusion is often observed in mild cognitive impairment, as-
suming to represent a compensatory response to an
encroaching neuropathology (Wierenga et al. 2012). Given
that the cognitive deficits are more prominent in elder
T2DM patients (>65 years old) than those at younger age
(Ryan and Geckle 2000), the elevated dACC perfusion in
the present study might reflect a vascular response to the in-
creased need of glucose and oxygen to achieve a normal cog-
nitive performance during the early stage. As lower dACC
perfusion was observed in more advanced patients
(Supplementary Fig. 1b), longitudinal studies are promising
to determine whether there is a breakdown in this compensa-
tory mechanism in progressive patients.
In the current results, the hypopefusion pattern in T2DM
was largely remained after the PVEs correction, which might
be attributed to the insignificant difference in the voxel-based
morphometry in GM as well as the total GM volume between
the two groups. More importantly, the remained results also
suggested that the hypoperfusion in T2DM patients were not
caused by the PVEs in the setting of potential cortical atrophy.
This is consistent with previous studies with subjects at high
risk for developing dementia, suggesting that perfusion defi-
cits may exist in presymptomatic stages before substantial
atrophy is present (Johnson et al. 2005; Xekardaki et al.
2015). However, noteworthy is that the formula we used for
the PVEs correction was based on the spatial resolution that is
different from ours (Johnson et al. 2005), which might poten-
tially confound the estimation of the corrected CBF values.
The more rigorous algorithm proposed by Asllani et al.
Table 2 Brain regions with significant differences in the CBFuncorr and
CBFcorr maps between T2DM patients and healthy controls (corrected
P < 0.05)
Brain regions MNI Voxels Peak T value
x y z
Uncorrected CBF map
Dorsal ACC +3 0 +33 124 +4.68
R MOG +24 -93 +3 161 -4.87
L MOG -21 -96 +3 139 -4.21
R Precuneus +9 -69 +51 77 -4.35
R PCC +9 -51 +21 53 -4.18
PVE corrected CBF map
Dorsal ACC +9 +9 +30 90 +5.00
R MOG +24 -93 +3 155 -4.88
L MOG -21 -93 +3 123 -4.24
R Precuneus +9 -69 +51 52 -4.10
Cuneus +9 -84 +15 60 -4.82
Comparisons were performed at P < 0.05, corrected by family-wise mul-
tiple comparison correction (AFNI software). MNI, Montreal
Neurological Institute; x, y, z, coordinates of primary peak locations in
the MNI space; positive T values: T2DM > control subjects; negative T
values: T2DM < control subjects. ACC, anterior cingulate cortex; PCC,
posterior cingulate cortex; MOG, middle occipital gyrus; R, right; L, left
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(Asllani et al. 2008) that reflects the pure tissue contribution
instead of the GM-to-WM flow ratios should be considered as
an alternative approach to overcome such limitation.
There are limitations to this study. First, the relatively small
sample size limited our ability to identify the CBF differences
among sub-groups of patients and to examine the relationship
between CBF and other clinical variables. More patients
should be included in future studies. Second, additional he-
modynamic measurements such as vascular reactivity were
not assessed. Inclusion of such measurements could further
facilitate our understanding of the vascular pathology in
T2DM patients. Finally, the statistical power of the current
study could be reduced by the heterogeneous medication of
the included participants. Further studies with non-treated
subjects are warranted to exclude such confounding effects.
In conclusion, the present study examined the regional ef-
fects of T2DM on cerebral perfusion. Hypoperfusion was ob-
served primarily in the PCC, precuneus and bilateral occipital
lobe, which was largely independent of potential cortical at-
rophy. Importantly, the hypoperfusion in the PCC and
precuneus was strongly correlated with increased IR level
and cognitive deficits, suggesting such hypoperfusion pattern
as a promising biomarker for cognitive impairment in T2DM
patients. Future studies are merited to explore the role of IR-
Fig. 3 Voxel-wise correlations between CBF maps and clinical
parameters. Results of the CBFuncorr map are shown in the Fig. 3a,
while the results of CBFcorr map are shown in Fig. 3b. HOMA-IR
index was negatively correlated with the perfusion in posterior regions,
especially PCC and precuneus (R2 = 0.35 [CBFuncorr map], R
2 = 0.25
[CBFcorr map]) (first row); CDT score was positively correlated with the
perfusion in PCC/precuneus region (R2 = 0.34 [CBFuncorr map], R
2 = 0.34
[CBFcorr map]) (second row). CFT score was positively correlated with
the perfusion in the right middle/inferior occipital gyrus (R2 = 0.41
[CBFuncorr map], R
2 = 0.40 [CBFcorr map]) (third row). HOMA-IR,
homeostasis model assessment of insulin resistance; PCC, posterior
cingulate cortex; dACC, dorsal anterior cingulate cortex. White squares
and dotted line, Control group; Black squares and solid lines, T2DM
group
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targeted treatment in the modulation of cerebral CBF and pre-
vention of dementia development in diabetic population.
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